Friday, June 9, 2023, 8:00 AM – 6:00 PM, Online, New York, NY
Overview
Pulmo-Oncology is an emerging discipline that has great importance to the clinical care of cancer patients. The respiratory system is often impacted by direct cancer involvement, infections, and toxicities stemming from the use of anti-neoplastic agents.
Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.
In this inaugural Symposium, clinical experts from Memorial Sloan Kettering (MSK) and other institutions will present an up-to-date overview of cutting-edge cancer therapies and best practice strategies in the evaluation and management of lung disease.
The purpose of this Symposium is to provide a state-of-the-art, case-based, multidisciplinary curriculum that addresses selected topics relevant to the respiratory health of patients with cancer.
Specialties
Who Should Attend
This Symposium is designed for healthcare professionals in pulmonology, hematology and oncology, and other disciplines involved in the care of cancer patients or who have a special interest in this area.
- Explain the role of pulmonologist in diagnosis and management of lung cancer
- Identify state of the art treatment strategies for management of lung cancer and check point inhibitor pneumonitis
- Implement strategies for diagnosis and management of infectious and non infectious complications of stem cell transplant
- Implement approaches to symptom management of cough and malignant pleural effusion related dyspnea
- Explain clinical significance of interstitial lung abnormalities and pulmonary fibrosis in lung cancer management
+ Topics:
CASE-BASED PANEL DISCUSSION- Intractable Cough Management in Cancer Patients.mp4
Idiopathic Pulmonary Fibrosis (IPF) and Lung Cancer Surgery.mp4
Idiopathic Pulmonary Fibrosis (IPF) and Lung Cancer Surgery.pdf
Idiopathic Pulmonary Fibrosis (IPF) and Non-Surgical Lung Cancer Therapies.mp4
Idiopathic Pulmonary Fibrosis (IPF) and Non-Surgical Lung Cancer Therapies.pdf
Immune Checkpoint Inhibitor Pneumonitis- A Pulmonologist’s Perspective.mp4
Immune Checkpoint Inhibitor Pneumonitis- A Pulmonologist’s Perspective.pdf
Interstitial Lung Abnormality (ILA).mp4
Interstitial Lung Abnormality (ILA).pdf
Intractable Cough in Cancer Patients.mp4
Intractable Cough in Cancer Patients.pdf
Keep it Cool- Bronchoscopic CryoCore Biopsies in the Oncologic Patient Population.mp4
Keep it Cool- Bronchoscopic CryoCore Biopsies in the Oncologic Patient Population.pdf
Management of Malignant Pleural Effusions.mp4
Management of Malignant Pleural Effusions.pdf
Management of Refractory Immune Checkpoint Inhibitor Pneumonitis- A Rheumatologist’s Perspective.mp4
Management of Refractory Immune Checkpoint Inhibitor Pneumonitis- A Rheumatologist’s Perspective.pdf
Pulmo-Oncology_2023_Brochure.pdf
Pulmonary Graft vs Host Disease (GVHD)- Management, Limitations and Future Directions.mp4
Pulmonary Graft vs Host Disease (GVHD)- Management, Limitations and Future Directions.pdf
Rechallenging Immune Checkpoint Inhibition After irAEs- Brave or Unwise..mp4
Rechallenging Immune Checkpoint Inhibition After irAEs- Brave or Unwise..pdf
Respiratory Infections In Transplant Cellular Therapy Recipients in The Era of Molecular Diagnostics.mp4
Respiratory Infections In Transplant Cellular Therapy Recipients in The Era of Molecular Diagnostics.pdf
Role of Pulmonologist in Diagnosis and Management of Lung Cancer.mp4
Role of Pulmonologist in Diagnosis and Management of Lung Cancer.pdf
Targeted and Immunologic Therapies for Lung cancer.mp4
Targeted and Immunologic Therapies for Lung cancer.pdf
